West Pharmaceutical Services (WST)
EBITDA Growth
13.50%
Quarterly · Period ending:
WST EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported13.50%period ending
Latest reported13.50%period ending
WST Quarterly EBITDA YoY % (33.49% → 13.50%)
Year-over-year change
High-resolution chart · PNG
WST ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 13.5013% | |
| 44.7979% | |
| 1.8969% | |
| 5.6962% | |
| 17.3862% | |
| -8.2675% | |
| 0.1949% | |
| -8.9539% | |
| -23.6913% | |
| -14.1888% | |
| 27.1375% | |
| 34.2058% | |
| -14.4732% | |
| -12.5057% | |
| -26.4357% | |
| -21.0056% | |
| 7.2434% | |
| 6.4626% | |
| 49.9658% | |
| 71.7514% | |
| 85.7033% | |
| 79.738% | |
| 38.5417% | |
| 34.3818% | |
| 20.6865% | |
| 17.3156% | |
| 11.983% | |
| 3.3632% | |
| 22.779% | |
| 19.1697% | |
| 9.27% | |
| 0.2247% | |
| 32.6284% | |
| -3.1915% | |
| 11.9326% | |
| 20.2703% | |
| -21.2842% | |
| 8.3227% | |
| 11.4162% | |
| 281.4433% | |
| 36.9707% | |
| 11.5714% | |
| 3.438% | |
| -71.2166% | |
| -21.4834% | |
| 12.5402% | |
| 11.8729% | |
| 8.5346% | |
| 22.956% | |
| -3.1153% | |
| 15% | |
| 34.7072% | |
| 46.5438% | |
| 5.7661% | |
| 13.5371% | |
| 2.4444% | |
| -8.4388% | |
| 25.1546% | |
| 78.2101% | |
| 2.9748% | |
| 55.4098% | |
| 3.8544% | |
| -36.0697% | |
| -1.7978% | |
| -32.6711% | |
| 27.9452% | |
| -10.6667% | |
| 31.6568% | |
| -32.1561% | |
| -10.5368% | |
| 162.0155% | |
| 35.8586% | |
| 44.9568% | |
| -34.5178% | |
| 8.7227% | |
| 40.4255% | |
| 5.7927% | |
| -24.5211% | |
| 9.5563% | |
| 40.2985% | |
| 17.1429% | |
| 74% | |
| 21.5768% | |
| -6.0748% | |
| 8.5271% | |
| 2.0408% | |
| 24.8705% | |
| 46.5753% | |
| 64.3312% | |
| -2% | |
| 6.6298% | |
| -29.1262% | |
| 5.3691% | |
| -18.0328% | |
| -17.3516% | |
| 83.9286% | |
| 166.0714% | |
| 120.4819% | |
| 95.5357% | |
| 3.7037% |